CENTUPLE GLOBAL LIMITED
Latest filings
- Postal Ballot notice published in newspapers · Compliance
- Postal Ballot: Auditor appointment and director designation change · Board & Shareholder Meetings
- Board approves new Statutory Auditor and Whole-time Director designation change · Management Changes
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹562 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from CENTUPLE GLOBAL LIMITED's filed financials and exchange disclosures
What does CENTUPLE GLOBAL LIMITED do?
CENTUPLE GLOBAL LIMITED is a Pharmaceuticals & Biotechnology company listed on BSE.
Is CENTUPLE GLOBAL LIMITED profitable?
Yes. Over the trailing twelve months CENTUPLE GLOBAL LIMITED reported a net profit of ₹1.23 Cr on revenue of ₹562 Cr.
Does CENTUPLE GLOBAL LIMITED pay a dividend?
Not in the latest reported year — CENTUPLE GLOBAL LIMITED's dividend payout for FY26 was nil.
Is CENTUPLE GLOBAL LIMITED debt-free?
No. It reported borrowings of ₹6.74 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹6.65 Cr after cash. Debt stands at 3.26× equity. That is higher than 99% of its 166 Pharmaceuticals peers.
Is CENTUPLE GLOBAL LIMITED expensive compared with its peers?
On trailing P/E, CENTUPLE GLOBAL LIMITED ranks 21 of 158 in Pharmaceuticals — cheaper than 87% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the CENTUPLE GLOBAL LIMITED share price move in a day?
On a typical session CENTUPLE GLOBAL LIMITED moves 2.40% — that is the median absolute close-to-close move across its last 266 trading days. MarketPing measures each filing's price reaction against it.
Where can I track CENTUPLE GLOBAL LIMITED's announcements?
Every NSE and BSE filing by CENTUPLE GLOBAL LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.